Belite Bio, IncBLTE

NASDAQHealthcareBiotechnology$164.11-3.21%

Focused on developing treatments for retinal degenerative diseases, the company is a clinical‑stage biopharmaceutical developer advancing small‑molecule therapies that target vitamin A transport pathways. Its lead candidate, tinlarebant, is being studied for conditions such as Stargardt disease and ...

Market Cap: $6.5B52W Range: $49.00 – $200.00

This page tracks all publicly disclosed congressional trades in Belite Bio, Inc (BLTE), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.

Total Disclosures

Unique Politicians

Buys

Sells

Congressional Trading History

No congressional trades found for this stock.

All stocks traded by Congress Full trade feed Most active traders About the STOCK Act Report missing trade

Belite Bio, IncBLTE

Congressional Trading History

Related